NEWS
Our Latest News
ARCHIMED acquires SeqCenter, a fast-growing player in cutting-edge DNA and RNA gene sequencing
SeqCenter is a category leader in Next-Generation Sequencing, which can sequence hundreds of thousands of genes in record-time and at low cost.
Global private equity healthcare specialist ARCHIMED announces the acquisition of Pittsburgh, Pennsylvania-based genetic sequencing provider SeqCenter. SeqCenter’s founding scientists initially worked at the University of Pittsburgh. Frustrated with the pace, cost and difficulty of obtaining sequencing data from existing vendors and academic core laboratories, they developed their own approach to gene sequencing, ultimately leaving academia and founding SeqCenter in 2019.
ARCHIMED buys four companies; HIS, Fytexia, Polyplus, and Micromed
September
20,
2016
ARCHIMED acquires Deallus Consulting
November
9,
2015
ARCHIMED acquires stakes in RehabWorks and Primo
November
9,
2015
ARCHIMED has acquired control of MediStream
September
9,
2014
368